|
|
||||||||




Departments of
*
Medical Microbiology and Immunology and
Pathology, University of Ulm, Ulm, Germany;
Roche Genetics, F. Hoffmann LaRoche, Basel, Switzerland;
Kirin Brewery, Pharmaceutical Research Laboratory, Gunma, Japan; and
¶ Ludwig Institute for Cancer Research, Epalinges, Switzerland
CD4+ 
T cells from either normal C57BL/6 (B6) or
MHC-II-deficient (A
-/- or A
-/-) B6
donor mice engrafted into congenic immunodeficient
RAG1-/- B6 hosts induced an aggressive inflammatory bowel
disease (IBD). Furthermore, CD4+ T cells from
CD1d-/- knockout (KO) B6 donor mice but not those from
MHC-I-/- (homozygous transgenic mice deficient for
2-microglobulin) KO B6 mice induced a colitis in
RAG-/- hosts. Abundant numbers of in vivo activated
(CD69highCD44highCD28high)
NK1+ and NK1- CD4+ T cells were
isolated from the inflamed colonic lamina propria (cLP) of transplanted
mice with IBD that produced large amounts of TNF-
and IFN-
but
low amounts of IL-4 and IL-10. IBD-associated cLP Th1 CD4+
T cell populations were polyclonal and MHC-II-restricted when derived
from normal B6 donor mice, but oligoclonal and apparently
MHC-I-restricted when derived from MHC-II-deficient
(A
-/- or A
-/-) B6 donor mice. cLP
CD4+ T cell populations from homozygous transgenic mice
deficient for
2-microglobulin KO B6 donor mice engrafted
into RAG-/- hosts were Th2 and MHC-II restricted. These
data indicate that MHC-II-dependent as well as MHC-II-independent
CD4+ T cells can induce a severe and lethal IBD in
congenic, immunodeficient hosts, but that the former need the latter to
express its IBD-inducing potential.
This article has been cited by other articles:
![]() |
P. Bochtler, C. Wahl, R. Schirmbeck, and J. Reimann Functional Adaptive CD4 Foxp3 T Cells Develop in MHC Class II-Deficient Mice J. Immunol., December 15, 2006; 177(12): 8307 - 8314. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bienvenu, B. Martin, C. Auffray, C. Cordier, C. Becourt, and B. Lucas Peripheral CD8+CD25+ T Lymphocytes from MHC Class II-Deficient Mice Exhibit Regulatory Activity J. Immunol., July 1, 2005; 175(1): 246 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takeshita, T. Yamasaki, S. Akira, F. Gantner, and K. B. Bacon Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse Int. Immunol., May 1, 2004; 16(5): 685 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Boyle and J. S. Hill Gaston Breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies Rheumatology, March 1, 2003; 42(3): 404 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Pinkoski, N. M. Droin, and D. R. Green Tumor Necrosis Factor alpha Up-regulates Non-lymphoid Fas-ligand following Superantigen-induced Peripheral Lymphocyte Activation J. Biol. Chem., October 25, 2002; 277(44): 42380 - 42385. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Boyle, J. C. Goodall, S. S. Opat, and J. S. H. Gaston The Recognition of HLA-B27 by Human CD4+ T Lymphocytes J. Immunol., September 1, 2001; 167(5): 2619 - 2624. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |